RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+5.61%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$4.8B
AUM Growth
+$4.8B
(-2%)
Cap. Flow
+$51.2M
Cap. Flow
% of AUM
1.07%
Top 10 Holdings %
Top 10 Hldgs %
55.46%
Holding
84
New
7
Increased
20
Reduced
15
Closed
24
Top Buys
| 1 |
Bruker
BRKR
|
$93.6M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$86M |
| 3 |
Orchestra BioMed
OBIO
|
$80.6M |
| 4 |
PTC Therapeutics
PTCT
|
$71.6M |
| 5 |
Axsome Therapeutics
AXSM
|
$49.4M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$83.7M |
| 2 |
Globus Medical
GMED
|
$55.5M |
| 3 |
Illumina
ILMN
|
$43.7M |
| 4 |
Regenxbio
RGNX
|
$41.9M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$37.3M |
Sector Composition
| 1 | Healthcare | 99.97% |
| 2 | Financials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXNX
26
DELISTED
Axonics, Inc. Common Stock
AXNX
| $48.3M | 1.01% |
884,974
| – | – |
|
27
Ventyx Biosciences
VTYX
$184M
| $46.5M | 0.97% |
1,388,881
-162,897
| -10% | -$5.46M |
|
|
CUTR
28
DELISTED
Cutera, Inc.
CUTR
| $43.6M | 0.91% |
1,846,596
+47,921
| +3% | +$1.13M |
|
29
Stoke Therapeutics
STOK
$1.08B
| $36.6M | 0.76% |
4,390,558
+519,577
| +13% | +$4.33M |
|
30
Tarsus Pharmaceuticals
TARS
$2.44B
| $32M | 0.67% |
2,548,125
| – | – |
|
31
scPharmaceuticals
SCPH
$296M
| $29.9M | 0.62% |
+3,297,843
| New | +$29.9M |
|
32
Adicet Bio
ACET
$60.8M
| $24.4M | 0.51% |
4,241,472
| – | – |
|
33
GH Research
GHRS
$870M
| $17.3M | 0.36% |
2,168,957
| – | – |
|
34
Viking Therapeutics
VKTX
$3.02B
| $16.7M | 0.35% |
+1,000,000
| New | +$16.7M |
|
35
Fulcrum Therapeutics
FULC
$353M
| $15.7M | 0.33% |
5,511,839
+518,560
| +10% | +$1.48M |
|
36
Outset Medical
OM
$245M
| $14.9M | 0.31% |
808,658
-100,994
| -11% | -$1.86M |
|
|
OLK
37
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $14.7M | 0.31% |
654,612
-327,306
| -33% | -$7.37M |
|
38
Mineralys Therapeutics
MLYS
$1.94B
| $14.4M | 0.3% |
+922,100
| New | +$14.4M |
|
39
PMV Pharmaceuticals
PMVP
$82.1M
| $14.3M | 0.3% |
2,999,098
-1,357,822
| -31% | -$6.48M |
|
40
Milestone Pharmaceuticals
MIST
$151M
| $12.8M | 0.27% |
3,256,102
-1,059,000
| -25% | -$4.17M |
|
41
Roivant Sciences
ROIV
$8.6B
| $11.5M | 0.24% |
1,552,717
+750,000
| +93% | +$5.54M |
|
42
MoonLake Immunotherapeutics
MLTX
$3.78B
| $10.7M | 0.22% |
500,000
| – | – |
|
43
Guardant Health
GH
$8.11B
| $10.1M | 0.21% |
430,887
| – | – |
|
|
DMTK
44
DELISTED
DermTech, Inc. Common Stock
DMTK
| $10M | 0.21% |
2,718,356
| – | – |
|
45
Apyx Medical
APYX
$71.9M
| $9.79M | 0.2% |
3,398,279
| – | – |
|
46
UroGen Pharma
URGN
$896M
| $7.92M | 0.17% |
857,464
| – | – |
|
47
Immunic
IMUX
$79.4M
| $6.4M | 0.13% |
4,294,459
+433,169
| +11% | +$645K |
|
|
ALLK
48
DELISTED
Allakos
ALLK
| $5.9M | 0.12% |
1,326,608
-316,892
| -19% | -$1.41M |
|
49
Castle Biosciences
CSTL
$673M
| $5.87M | 0.12% |
258,498
-258,497
| -50% | -$5.87M |
|
50
Immatics
IMTX
$662M
| $5.83M | 0.12% |
845,000
| – | – |
|